mounjaro a glp 1 GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 Lilly's Mounjaro tops other GLP-1s

For prospective patients, the practical implication is straightforward: marketing copy you read on Strut today may differ materially from copy you read in January 2026, and any "FDA-approved"-adjacent language about compounded products should be treated skeptically across every platform not just Strut

A reliable digital bathroom scale that measures to at least 0.1 kg precision is recommended

In recent years, research has shown that GLP-1s may help with a variety of conditions, including obstructive sleep apnea, heart disease, and chronic kidney disease

By using Semaglutide GLP-1 to regulate appetite and improve insulin response, Watson creates a foundation for steady fat reduction and improved metabolic health without extreme dieting

Late side effects still deserve attention

A very different world